Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 65 (1), 3-14
- https://doi.org/10.1023/a:1026246500788
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusionJournal of Neurosurgery, 2002
- Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with singlephoton emission computerized tomography imagingJournal of Neurosurgery, 1997
- Human neurological cancer cells express interleukin‐4 (IL‐4) receptors which are targets for the toxic effects of IL4‐pseudomonas exotoxin chimeric proteinInternational Journal of Cancer, 1994
- Recording neurological impairment in clinical trials of gliomaJournal of Neuro-Oncology, 1994
- Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin SelectivityScience, 1987
- Transferrin receptor on endothelium of brain capillariesNature, 1984
- Immunotoxins: Hybrid Molecules Combining High Specificity and Potent CytotoxicityImmunological Reviews, 1982
- Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cellsNature, 1981
- Transferrin binding by human lymphoblastoid cell lines and other transformed cellsCellular Immunology, 1980
- Modulation of cell surface iron transferrin receptors by cellular density and state of activationJournal of Supramolecular Structure, 1979